Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Resorbable MAGnesium Scaffold (Freesolve) in the Treatment of Subjects With Long de Novo Lesions in Native Coronary Arteries: BIOMAG-LL

NCT07091682 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.

NCT NCT07091682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07091682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK - Safety and Clinical Performance of the Drug Eluting Resorbable MAGnesium Scaffold (Freesolve) in the Treatment of Subjects With Long de Novo Lesions in Native Coronary Arteries: BIOMAG-LL
Lead sponsor
Biotronik AG
Phase
Not applicable
Overall status
Recruiting
Start date
February 18, 2025
Completion date
June 30, 2031
Enrollment
100 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, angina pectoris, atherosclerosis of coronary artery, coronary artery disease, ischemic heart disease, myocardial ischemia